{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:01:49Z","timestamp":1769155309555,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00423-021-02324-4","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T17:02:42Z","timestamp":1636045362000},"page":"885-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["State-of-the-art surgery for Crohn\u2019s disease: Part I\u2014small intestine\/ileal disease"],"prefix":"10.1007","volume":"407","author":[{"given":"Sandra L.","family":"Kavalukas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina M.","family":"Scheurlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-5263","authenticated-orcid":false,"given":"Susan","family":"Galandiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"2324_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jama.1932.02740680019005","volume":"99","author":"BB Crohn","year":"1932","unstructured":"Crohn BB, Ginzburg L, Oppenheimer GD (1932) Regional ileitis: a pathologic and clinical entity. J Am Med Assoc 99:1323\u20131329. https:\/\/doi.org\/10.1001\/jama.1932.02740680019005","journal-title":"J Am Med Assoc"},{"key":"2324_CR2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769\u20132778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"2324_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel J-F (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749\u2013753. https:\/\/doi.org\/10.1136\/gut.2005.082909","journal-title":"Gut"},{"key":"2324_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/gast.1996.v111.pm8780560","volume":"111","author":"JM Polito II","year":"1996","unstructured":"Polito JM II, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM (1996) Crohn\u2019s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111:580\u2013586. https:\/\/doi.org\/10.1053\/gast.1996.v111.pm8780560","journal-title":"Gastroenterology"},{"key":"2324_CR5","first-page":"862","volume":"85","author":"H Elloumi","year":"2007","unstructured":"Elloumi H, Sfar S, Ben Abdelaziz A, Arfaoui D, Mouna G, Ajmi S (2007) Crohn\u2019s disease: influence of age at diagnosis on clinical type of disease. Tunis Med 85:862\u2013865","journal-title":"Tunis Med"},{"key":"2324_CR6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, ACCENT I Study Group et al (2002) Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet. 359:1541\u20131549. https:\/\/doi.org\/10.1016\/S0140-6736(02)08512-4","journal-title":"Lancet."},{"key":"2324_CR7","unstructured":"European Medicines Agency. https:\/\/www.ema.europa.eu\/en. Accessed August 1, 2021"},{"key":"2324_CR8","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/S0140-6736(18)32196-2","volume":"393","author":"BD Ye","year":"2019","unstructured":"Ye BD, Pesegova M, Alexeeva O et al (2019) Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn\u2019s disease: an international, randomised, double-blind, phase 3 non-inferiority study. Lancet 393:1699\u20131707. https:\/\/doi.org\/10.1016\/S0140-6736(18)32196-2","journal-title":"Lancet"},{"key":"2324_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/ecco-jcc\/jjaa001","volume":"14","author":"M Lukas","year":"2020","unstructured":"Lukas M, Malickova K, Kolar M et al (2020) Switching from originator adalimumab to the biosimilar SB5 in patients with inflammatory bowel disease: short-term experience from a single tertiary clinical centre. J Crohns Colitis 14:915\u2013919. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa001","journal-title":"J Crohns Colitis"},{"issue":"3","key":"2324_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.17235\/reed.2020.6693\/2019","volume":"112","author":"DG Ribaldone","year":"2020","unstructured":"Ribaldone DG, Caviglia GP, Pellicano R et al (2020) Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn\u2019s disease: an observational study. Rev Esp Enferm Dig 112(3):195\u2013200. https:\/\/doi.org\/10.17235\/reed.2020.6693\/2019","journal-title":"Rev Esp Enferm Dig"},{"key":"2324_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5694\/mja2.50824","volume":"214","author":"C Haifer","year":"2021","unstructured":"Haifer C, Srinivasan A, An Y-K et al (2021) Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study. Med J Aust 214:128\u2013133. https:\/\/doi.org\/10.5694\/mja2.50824","journal-title":"Med J Aust"},{"key":"2324_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ibd.21825","volume":"18","author":"P De Cruz","year":"2012","unstructured":"De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV (2012) Postoperative recurrent luminal Crohn\u2019s disease: a systematic review. Inflamm Bowel Dis 18:758\u2013777. https:\/\/doi.org\/10.1002\/ibd.21825","journal-title":"Inflamm Bowel Dis"},{"key":"2324_CR13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","volume":"145","author":"AD Frolkis","year":"2013","unstructured":"Frolkis AD, Dykeman J, Negr\u00f3n ME et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996\u20131006. https:\/\/doi.org\/10.1053\/j.gastro.2013.07.041","journal-title":"Gastroenterology"},{"key":"2324_CR14","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1148\/rg.307105052","volume":"30","author":"KM Elsayes","year":"2010","unstructured":"Elsayes KM, Al-Hawary MM, Jagdish J, Ganesh HS, Platt JF (2010) CT enterography: principles, trends, and interpretation of findings. Radiographics 30:1955\u20131970. https:\/\/doi.org\/10.1148\/rg.307105052","journal-title":"Radiographics"},{"key":"2324_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/1751-2980.12213","volume":"16","author":"C Estay","year":"2015","unstructured":"Estay C, Simian D, Lubascher J, Figueroa C, O\u2019Brien A, Quera R (2015) Ionizing radiation exposure in patients with inflammatory bowel disease: are we overexposing our patients? J Dig Dis 16:83\u201389. https:\/\/doi.org\/10.1111\/1751-2980.12213","journal-title":"J Dig Dis"},{"key":"2324_CR16","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1097\/MIB.0b013e31828c844f","volume":"19","author":"YS Jung","year":"2013","unstructured":"Jung YS, Park DI, Kim ER et al (2013) Quantifying exposure to diagnostic radiation and factors associated with exposure to high levels of radiation in Korean patients with inflammatory bowel disease. Inflamm Bowel Dis 19:1852\u20131857. https:\/\/doi.org\/10.1097\/MIB.0b013e31828c844f","journal-title":"Inflamm Bowel Dis"},{"key":"2324_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00000658-199610000-00014","volume":"224","author":"VW Fazio","year":"1996","unstructured":"Fazio VW, Marchetti F, Church M et al (1996) Effect of resection margins on the recurrence of Crohn\u2019s disease in the small bowel. A randomized controlled trial. Ann Surg 224:563\u2013571. https:\/\/doi.org\/10.1097\/00000658-199610000-00014","journal-title":"Ann Surg"},{"key":"2324_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-021-03941-7","author":"M Zemel","year":"2021","unstructured":"Zemel M, Solo E, Tulchinsky H (2021) Does microscopic involvement of the surgical margins after ileocecectomy in Crohn\u2019s patients predict early recurrence? Int J Colorectal Dis. https:\/\/doi.org\/10.1007\/s00384-021-03941-7","journal-title":"Int J Colorectal Dis"},{"key":"2324_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/DCR.0000000000001407","volume":"62","author":"JM Ryan","year":"2019","unstructured":"Ryan JM, Rogers AC, O\u2019Toole A, Burke JP (2019) Meta-analysis of histological margin positivity in the prediction of recurrence after Crohn\u2019s resection. Dis Colon Rectum 62:882\u2013892. https:\/\/doi.org\/10.1097\/DCR.0000000000001407","journal-title":"Dis Colon Rectum"},{"key":"2324_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cgh.2019.04.045","volume":"18","author":"N Hammoudi","year":"2020","unstructured":"Hammoudi N, Cazals-Hatem D, Auzolle C, REMIND Study Group Investigators et al (2020) Association between microscopic lesions at ileal resection margin and recurrence after surgery in patients with Crohn\u2019s disease. Clin Gastroenterol Hepatol 18:141-149.e2. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.045","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2324_CR21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/ecco-jcc\/jjx187","volume":"12","author":"CJ Coffey","year":"2018","unstructured":"Coffey CJ, Kiernan MG, Sahebally SM et al (2018) Inclusion of the mesentery in ileocolic resection for Crohn\u2019s disease is associated with reduced surgical recurrence. J Crohns Colitis 12:1139\u20131150. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx187","journal-title":"J Crohns Colitis"},{"key":"2324_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/(SICI)1096-9896(200002)190:2<196:AID-PATH513>3.0.CO;2-5","volume":"190","author":"NR Borley","year":"2000","unstructured":"Borley NR, Mortensen NJ, Jewell DP, Warren BF (2000) The relationship between inflammatory and serosal connective tissue changes in ileal Crohn\u2019s disease: evidence for a possible causative link. J Pathol 190:196\u2013202. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(200002)190:2%3c196:AID-PATH513%3e3.0.CO;2-5","journal-title":"J Pathol"},{"key":"2324_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13063-020-4105-x","volume":"21","author":"Y Li","year":"2020","unstructured":"Li Y, Mohan H, Lan N et al (2020) Mesenteric excision surgery or conservative limited resection in Crohn\u2019s disease: study protocol for an international, multicenter, randomized controlled trial. Trials 21:210. https:\/\/doi.org\/10.1186\/s13063-020-4105-x","journal-title":"Trials"},{"key":"2324_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","volume":"35","author":"L Pironi","year":"2016","unstructured":"Pironi L, Arends J, Bozzetti F, Home artificial nutrition & chronic intestinal failure special interest group of ESPEN et al (2016) ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 35:247\u2013307. https:\/\/doi.org\/10.1016\/j.clnu.2016.01.020","journal-title":"Clin Nutr"},{"key":"2324_CR25","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/ibd.21331","volume":"16","author":"B Baca","year":"2010","unstructured":"Baca B, Ozben V, Boler DE et al (2010) Effect of corticosteroid dose and duration of administration on colonic anastomosis. Inflamm Bowel Dis 16:2162\u20132167. https:\/\/doi.org\/10.1002\/ibd.21331","journal-title":"Inflamm Bowel Dis"},{"key":"2324_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.clnu.2019.11.002","volume":"39","author":"SC Bischoff","year":"2020","unstructured":"Bischoff SC, Escher J, H\u00e9buterne X et al (2020) ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr 39:632\u2013653. https:\/\/doi.org\/10.1016\/j.clnu.2019.11.002","journal-title":"Clin Nutr"},{"key":"2324_CR27","first-page":"57","volume":"18","author":"FG Campos","year":"2003","unstructured":"Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Kiss DR, Habr-Gama A (2003) Pharmacological nutrition in inflammatory bowel diseases. Nutr Hosp 18:57\u201364","journal-title":"Nutr Hosp"},{"key":"2324_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF02049480","volume":"39","author":"F Michelassi","year":"1996","unstructured":"Michelassi F (1996) Side-to-side isoperistaltic strictureplasty for multiple Crohn\u2019s strictures. Dis Colon Rectum 39:345\u2013349. https:\/\/doi.org\/10.1007\/BF02049480","journal-title":"Dis Colon Rectum"},{"key":"2324_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/SLA.0000000000003430","volume":"271","author":"D Mege","year":"2020","unstructured":"Mege D, Michelassi F, Michelassi II (2020) Michelassi II strictureplasty for Crohn\u2019s disease: a new side-to-side isoperistaltic strictureplasty with discontinuous bowel loops. Ann Surg 271:e1\u2013e2. https:\/\/doi.org\/10.1097\/SLA.0000000000003430","journal-title":"Ann Surg"},{"key":"2324_CR30","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1007\/s10350-007-0279-5","volume":"50","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Fazio VW, Tekkis PP (2007) Safety and efficacy of strictureplasty for Crohn\u2019s disease: a systematic review and meta-analysis. Dis Colon Rectum 50:1968\u20131986. https:\/\/doi.org\/10.1007\/s10350-007-0279-5","journal-title":"Dis Colon Rectum"},{"key":"2324_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/s1072-7515(01)00775-x","volume":"192","author":"DW Dietz","year":"2001","unstructured":"Dietz DW, Laureti S, Strong SA et al (2001) Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn\u2019s disease. J Am Coll Surg 192:330\u2013337. https:\/\/doi.org\/10.1016\/s1072-7515(01)00775-x","journal-title":"J Am Coll Surg"},{"key":"2324_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10151-020-02268-9","volume":"24","author":"V Celentano","year":"2020","unstructured":"Celentano V, Beable R, Ball C et al (2020) Feasibility of intraoperative ultrasound of the small bowel during Crohn\u2019s disease surgery. Tech Coloproctol 24:965\u2013969. https:\/\/doi.org\/10.1007\/s10151-020-02268-9","journal-title":"Tech Coloproctol"},{"key":"2324_CR33","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology 99:956\u2013963. https:\/\/doi.org\/10.1016\/0016-5085(90)90613-6","journal-title":"Gastroenterology"},{"key":"2324_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s10350-004-0786-6","volume":"48","author":"A Resegotti","year":"2005","unstructured":"Resegotti A, Astegiano M, Farina EC et al (2005) Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn\u2019s disease surgery. Dis Colon Rectum 48:464\u2013468. https:\/\/doi.org\/10.1007\/s10350-004-0786-6","journal-title":"Dis Colon Rectum"},{"key":"2324_CR35","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s10620-014-3039-0","volume":"59","author":"X He","year":"2014","unstructured":"He X, Chen Z, Huang J et al (2014) Stapled side-to-side anastomosis might be better than handsewn end-to-end anastomosis in ileocolic resection for Crohn\u2019s disease: a meta-analysis. Dig Dis Sci 59:1544\u20131551. https:\/\/doi.org\/10.1007\/s10620-014-3039-0","journal-title":"Dig Dis Sci"},{"key":"2324_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/DCR.0b013e318208b90f","volume":"54","author":"T Kono","year":"2011","unstructured":"Kono T, Ashida T, Ebisawa Y et al (2011) A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn\u2019s disease. Dis Colon Rectum 54:586\u2013592. https:\/\/doi.org\/10.1007\/DCR.0b013e318208b90f","journal-title":"Dis Colon Rectum"},{"key":"2324_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1055\/s-0040-1714236","volume":"33","author":"T Kono","year":"2020","unstructured":"Kono T, Fichera A (2020) Surgical treatment for Crohn\u2019s disease: a role of Kono-S anastomosis in the west. Clin Colon Rectal Surg 33:335\u2013343. https:\/\/doi.org\/10.1055\/s-0040-1714236","journal-title":"Clin Colon Rectal Surg"},{"key":"2324_CR38","first-page":"111","volume":"90","author":"R Fornaro","year":"2019","unstructured":"Fornaro R, Caristo G, Stratta E et al (2019) Crohn\u2019s disease and postoperative recurrence. The role of anastomotic configurations and the Kono-s anastomosis. Ann Ital Chir 90:111\u2013120","journal-title":"Ann Ital Chir"},{"key":"2324_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11605-018-4012-6","volume":"23","author":"N Shimada","year":"2019","unstructured":"Shimada N, Ohge H, Kono T et al (2019) Surgical recurrence at anastomotic site after bowel resection in Crohn\u2019s disease: comparison of Kono-S and end-to-end anastomosis. J Gastrointest Surg 23:312\u2013319. https:\/\/doi.org\/10.1007\/s11605-018-4012-6","journal-title":"J Gastrointest Surg"},{"key":"2324_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11605-015-3061-3","volume":"20","author":"T Kono","year":"2016","unstructured":"Kono T, Fichera A, Maeda K et al (2016) Kono-S Anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn\u2019s disease: an international multicenter study. J Gastrointest Surg 20:783\u2013790. https:\/\/doi.org\/10.1007\/s11605-015-3061-3","journal-title":"J Gastrointest Surg"},{"key":"2324_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/codi.15136","volume":"23","author":"A Alshantti","year":"2021","unstructured":"Alshantti A, Hind D, Hancock L, Brown SR (2021) The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn\u2019s disease: a systematic review. Colorectal Dis 23:7\u201317. https:\/\/doi.org\/10.1111\/codi.15136","journal-title":"Colorectal Dis"},{"key":"2324_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0140-6736(91)90663-a","volume":"338","author":"P Rutgeerts","year":"1991","unstructured":"Rutgeerts P, Goboes K, Peeters M et al (1991) Effect of faecal stream diversion on recurrence of Crohn\u2019s disease in the neoterminal ileum. Lancet 338:771\u2013774. https:\/\/doi.org\/10.1016\/0140-6736(91)90663-a","journal-title":"Lancet"},{"issue":"5","key":"2324_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.dld.2016.01.009","volume":"48","author":"S Onali","year":"2016","unstructured":"Onali S, Calabrese E, Petruzziello C et al (2016) Post-operative recurrence of Crohn\u2019s disease: a prospective study at 5 years. Dig Liver Dis 48(5):489\u2013494. https:\/\/doi.org\/10.1016\/j.dld.2016.01.009","journal-title":"Dig Liver Dis"},{"key":"2324_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","volume":"136","author":"M Regueiro","year":"2009","unstructured":"Regueiro M, Schraut W, Baidoo L et al (2009) Infliximab prevents Crohn\u2019s disease recurrence after ileal resection. Gastroenterology 136:441\u201350.e1. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.051","journal-title":"Gastroenterology"},{"key":"2324_CR45","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1016\/j.crohns.2013.04.020","volume":"7","author":"A Armuzzi","year":"2013","unstructured":"Armuzzi A, Felice C, Papa A et al (2013) Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn\u2019s disease: an open-label pilot study. J Crohns Colitis 7:e623\u2013e629. https:\/\/doi.org\/10.1016\/j.crohns.2013.04.020","journal-title":"J Crohns Colitis"},{"key":"2324_CR46","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/ajg.2013.287","volume":"108","author":"E Savarino","year":"2013","unstructured":"Savarino E, Bodini G, Dulbecco P et al (2013) Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn\u2019s disease: a randomized controlled trial. Am J Gastroenterol 108:1731\u20131742. https:\/\/doi.org\/10.1038\/ajg.2013.287","journal-title":"Am J Gastroenterol"},{"key":"2324_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/ecco-jcc\/jjz004","volume":"13","author":"PM Neary","year":"2019","unstructured":"Neary PM, Aiello AC, Stocchi L et al (2019) High-risk ileocolic anastomoses for Crohn\u2019s disease: when is diversion indicated? J Crohns Colitis 13:856\u2013863. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz004","journal-title":"J Crohns Colitis"},{"key":"2324_CR48","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archsurg.2010.40","volume":"145","author":"DA Telem","year":"2010","unstructured":"Telem DA, Chin EH, Nguyen SQ, Divino CM (2010) Risk factors for anastomotic leak following colorectal surgery: a case-control study. Arch Surg 145:371\u2013376. https:\/\/doi.org\/10.1001\/archsurg.2010.40","journal-title":"Arch Surg"},{"key":"2324_CR49","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/DCR.0b013e318247c433","volume":"55","author":"A Tzivanakis","year":"2012","unstructured":"Tzivanakis A, Singh JC, Guy RJ, Travis SPL, Mortensen NJ, George BD (2012) Influence of risk factors on the safety of ileocolic anastomosis in Crohn\u2019s disease surgery. Dis Colon Rectum 55:558\u2013562. https:\/\/doi.org\/10.1097\/DCR.0b013e318247c433","journal-title":"Dis Colon Rectum"},{"key":"2324_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","volume":"2","author":"CY Ponsioen","year":"2017","unstructured":"Ponsioen CY, de Groof EJ, Eshuis EJ, LIR!C study group et al (2017) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol 2:785\u2013792. https:\/\/doi.org\/10.1016\/S2468-1253(17)30248-0","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2324_CR51","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S2468-1253(20)30117-5","volume":"5","author":"TW Stevens","year":"2020","unstructured":"Stevens TW, Haasnoot ML, D\u2019Haens GR, LIR!C study group et al (2020) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: retrospective long-term follow-up of the LIR!C trial. Lancet Gastroenterol Hepatol 5:900\u2013907. https:\/\/doi.org\/10.1016\/S2468-1253(20)30117-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2324_CR52","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2018-317539","volume":"68","author":"EJ de Groof","year":"2019","unstructured":"de Groof EJ, Stevens TW, Eshuis EJ, LIR!C study group et al (2019) Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn\u2019s disease: the LIR!C Trial. Gut 68:1774\u20131780. https:\/\/doi.org\/10.1136\/gutjnl-2018-317539","journal-title":"Gut"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-021-02324-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T06:03:52Z","timestamp":1653890632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-021-02324-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2324"],"URL":"https:\/\/doi.org\/10.1007\/s00423-021-02324-4","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"1 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Kavalukas and Scheurlen have no conflict of interest. Dr. Galandiuk is the Editor-in-Chief of <i>Diseases of the Colon and Rectum<\/i> and is the Director of the Price Institute of Surgical Research and receives support from AbbVie for clinical research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}